ImpediMed Limited Stock
Stocks
IPD
AU000000IPD8
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Australian S.E.
01:13:50 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 0.005000 AUD | 0.00% |
|
0.00% | -85.29% |
| 07-27 | ImpediMed Limited, Q4 2026 Earnings Call, Jul 28, 2026 | |
| 06-10 | ImpediMed Limited - Shareholder/Analyst Call |
| Market Cap | 18.31M 12.93M 11.21M 10.53M 9.58M 18.01M 1.23B 124M 48.31M 619M 48.55M 47.49M 2.06B | P/E 2026 * |
-0.68x | P/E 2027 * | -1.61x |
|---|---|---|---|---|---|
| Enterprise Value | 11.96M 8.45M 7.32M 6.88M 6.26M 11.76M 806M 80.73M 31.55M 404M 31.71M 31.02M 1.35B | EV / Sales 2026 * |
0.81x | EV / Sales 2027 * | 1.09x |
| Free-Float |
89.16% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ImpediMed Limited
| 01-30 | Bell Potter rates IPD as Speculative Buy | AQ |
| 01-30 | Morgans rates IPD as Speculative Buy | AQ |
| 25-02-10 | ImpediMed Secures $15m Growth Capital Funding | AQ |
| 24-07-04 | Morgans rates IPD as Add | AQ |
| 24-04-30 | Ord Minnett rates IPD as Speculaitve Buy | AQ |
| Current month | +11.11% | ||
| 1 month | -9.09% | ||
| 3 months | -37.50% | ||
| 6 months | -72.22% | ||
| Current year | -85.29% |
| 1 week | 0 |  | 0.01 |
| 1 month | 0 | | 0.01 |
| Current year | 0 | | 0.04 |
| 1 year | 0 | | 0.06 |
| 3 years | 0 | | 0.21 |
| 5 years | 0 | | 0.24 |
| 10 years | 0 | | 1.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Anderson
CEO | Chief Executive Officer | - | 2026-04-06 |
McGregor Grant
DFI | Director of Finance/CFO | - | 2023-11-19 |
Steven Chen
CTO | Chief Tech/Sci/R&D Officer | - | 2023-09-25 |
| Director | Title | Age | Since |
|---|---|---|---|
McGregor Grant
CHM | Chairman | - | - |
| Chairman | - | 2024-02-25 | |
Janelle Delaney
BRD | Director/Board Member | - | 2023-09-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/16/26 | Buy | Chairman | 146,408 | 0.0072% | ||
| 1/16/26 | Buy | Director | 100,563 | 0.0049% | ||
| 1/16/26 | Buy | Director | 100,563 | 0.0049% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -88.64% | -97.50% | 12.96M | |
| -1.18% | +3.13% | +24.82% | +9.58% | 223B | |
| -0.92% | +2.12% | -0.89% | -20.17% | 145B | |
| 0.00% | +6.95% | -16.09% | +31.78% | 142B | |
| +0.53% | +8.27% | -49.64% | +1.29% | 74.52B | |
| -0.53% | +4.04% | +20.32% | +16.56% | 53.63B | |
| +0.03% | -0.51% | -15.63% | -17.27% | 50.14B | |
| +0.71% | +5.80% | +27.25% | +17.68% | 41.87B | |
| -0.63% | +3.38% | +44.83% | +41.78% | 40.89B | |
| +2.09% | +5.05% | -0.83% | +3.07% | 32.65B | |
| Average | +0.09% | +3.81% | -5.45% | -1.32% | 80.31B | |
| Weighted average by Cap. | -0.34% | +4.56% | +3.33% | +7.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14.72M 10.4M 9.01M 8.46M 7.7M 14.48M 992M 99.37M 38.84M 498M 39.02M 38.18M 1.66B | 19.64M 13.87M 12.02M 11.29M 10.27M 19.32M 1.32B 133M 51.81M 664M 52.06M 50.93M 2.21B |
| Net income | -21.71M -15.33M -13.29M -12.48M -11.36M -21.35M -1.46B -147M -57.27M -734M -57.55M -56.3M -2.44B | -12.49M -8.82M -7.65M -7.18M -6.53M -12.28M -842M -84.3M -32.95M -422M -33.1M -32.39M -1.41B |
| Net Debt | -6.35M -4.49M -3.89M -3.65M -3.32M -6.25M -428M -42.88M -16.76M -215M -16.84M -16.48M -715M | 3.01M 2.13M 1.85M 1.73M 1.58M 2.97M 203M 20.35M 7.95M 102M 7.99M 7.82M 339M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-13 | A$0.005000 | 0.00% | 6,544 |
| 26-08-12 | A$0.005000 | -16.67% | 1,169,170 |
| 26-08-11 | A$0.006000 | 0.00% | 13,666 |
| 26-08-10 | A$0.006000 | 0.00% | 3,537,768 |
| 26-08-07 | A$0.006000 | 0.00% | 881,256 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IPD Stock
Select your edition
All financial news and data tailored to specific country editions
